Search Results

You searched for : AbbVie  

Sightsavers India and AbbVie India Advance Nationwide Glaucoma Awareness Efforts in Jaipur

Sightsavers India, in collaboration with AbbVie Therapeutics India Pvt. Ltd., continued its national drive to address glaucoma-related visual impairment by convening a state-level ...
Mar 24

Allergan Aesthetics Helps Empower Consumers through Education as Medical Aesthetic Treatment Demand Grows

Allergan Aesthetics, an AbbVie company, has announced the launch of A–Z of Medical Aesthetics, a consumer education initiative to improve understanding of aesthetics and ...
Mar 23

BioAsia 2026 to Convene the World’s Leading Science, AI, and Industry Pioneers Driving the TechBio Revolution

Global innovators shaping AI-native biology, next-generation medicines and digital-first healthcare to chart the future of global health....
Feb 05

The Indian Pharmaceutical Alliance Welcomes New Leadership to Drive the Next Phase of Growth

The Indian Pharmaceutical Alliance (IPA) today announced a leadership transition, with Dr. Sharvil Patel, Managing Director of Zydus Lifesciences and former Vice President of IPA, ...
Oct 03

AbbVie Hosts National Conclave on World Retina Day to Spotlight Rising Burden of Diabetic Macular Edema

Leading Retina Specialists and Endocrinologists unite to emphasize the urgent need for early detection, wider access to treatment, and stronger policy support to address diabetes-...
Sep 24

Bihar Hosts Fifth State-Level Consultation on Glaucoma Prevention

A panel discussion followed, bringing together specialists who discussed various approaches to managing glaucoma. This was followed by an interactive Q&A session, during which ...
Mar 10

Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on Prevention of Visual Impairment Caused by Glaucoma

The screenings served as a valuable resource, ensuring that timely interventions could be made for those in need of further diagnosis and treatment, reinforcing the ...
Nov 16

Bhopal Hosts Third State-Level Consultation on Glaucoma Prevention

A panel discussion followed which brought together specialists who discussed various approaches to managing glaucoma, followed by an interactive Q&A session where attendees had ...
Sep 23

Sightsavers India and AbbVie India Hosted a State-Level Consultation on Prevention of Visual Impairment Caused by Glaucoma in Lucknow

The consultation also featured a free glaucoma screening session for attendees aged 40 and above, led by Dr Suneeta Dubey and her team, ensuring participants ...
Aug 26

Sightsavers India and AbbVie India Host Successful State-Level Consultation on Glaucoma Awareness

A highlight of the event was the glaucoma screening offered to attendees aged 40 and above, ensuring that participants had access to immediate and practical ...
Jun 29

AbbVie India and Sightsavers India Collaborate to Raise Awareness on Glaucoma

...
May 02

AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research

Latest pharma news updates...
Nov 12

AbbVie, Eisai, and EA Pharma launch “Humira support tool ordering service for Patients”

Latest pharma news update...
Sep 16

Mission and AbbVie collaboration in Alzheimer’s and Parkinson’s diseases reaches next milestone

Latest Pharma News Update...
Aug 10

AbbVie and Calico announce Second Extension of collaboration focused on aging and age-related Diseases

Latest Pharma Update...
Jul 30

Top pharma stocks for long term investing : The companies to watch for in next 5 years

The pharma stocks for long term wealth creation ...
Jan 11

Harbour BioMed and Utrecht University Announce License Agreement with AbbVie and Initiation of COVID-19 Antibody Clinical Trials

Harbour BioMed, and Utrecht University today announced that they licensed to AbbVie their fully human, SARS-CoV-2 neutralizing antibody, 47D11 and program, for the ...
Dec 15

I-Mab accelerates clinical development of anti-CD47 monoclonal antibody lemzoparlimab in the US and China

I-Mab's global collaboration with AbbVie will facilitate global development of lemzoparlimab...
Dec 05

AbbVie and Frontier Medicines establish global partnership for research and development

The partnership will address novel therapies and E3 Degraders against difficult-to-drug targets...
Dec 04

Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Tentative Approval for Testosterone Gel

Testosterone Gel, is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone....
Nov 25

Alembic Pharmaceuticals announces USFDA Final Approval for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg.

Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg have an estimated market size of US$ 17 million for twelve months ending June 2020 ...
Oct 21

AbbVie submits regulatory applications to US FDA and EMA for RINVOQ (upadacitinib) in atopic dermatitis

These submissions are an important step forward in the commitment to providing an additional treatment option ...
Oct 20

AbbVie received US FDA approval for the treatment of acute myeloid leukemia

...
Oct 17

Eli Lilly announces agreement to acquire Disarm Therapeutics

Eli Lilly successfully develop and commercialize new medicines resulting from the acquisition...
Oct 16

NIH study aims to identify promising COVID-19 treatments for larger clinical trials

Approximately 100 hospitalized volunteers will be assigned to each study arm with each of the study sites testing no more than three investigational treatments at ...
Oct 14

25 Matching result(s) found!

-Advertisements-



Trending Now

Clinical Interventions in Chronic Hepatitis B and C: Antiviral Efficacy, Liver Fibrosis Scoring, and Monitoring August 11, 2026
Common Health Mistakes Indians Should Avoid: A Practical Guide to Everyday WellnessAugust 11, 2026
How to Build a Healthy Lifestyle After 40: A Practical Guide for Indian AdultsAugust 11, 2026
Milk Microbiome Could Hold New Clues to Lifelong Health, Experts SayAugust 10, 2026
Globally Renowned Dermatologist and Sesderma Founder Professor Dr. Gabriel Serrano to Visit India to Showcase Cutting-Edge Derma-Tech for Indian Skincare at Scientific Symposiums Hosted by Iberia PharmaceuticalsAugust 10, 2026
Sharda Hospital Celebrates World Breastfeeding Week with a Week-Long Awareness ProgrammeAugust 10, 2026
Swinburne University of Technology Opens Applications for Master of Engineering ScienceAugust 10, 2026
GLP-1 Receptor Agonists: A New Era in Weight Loss TreatmentAugust 10, 2026
Immunotherapy vs. Chemotherapy: Understanding the Mechanisms of Precision OncologyAugust 10, 2026
Mitigating Tech-Induced Ailments: Managing Screen Time, Sedentary Lifestyles, and Dry Eye SyndromeAugust 10, 2026
The Blueprint of Validation: Navigating Medical AI’s "Reckoning Year"August 10, 2026
The Future of Smart Hospitals: Redefining Healthcare Delivery in India August 10, 2026
Healthcare Data Security in India: Risks, Threats, and Best Practices for a Digital-First Health EcosystemAugust 10, 2026
The Science of Resilience: Psychological Strategies for Modern StressAugust 08, 2026
The Science of Fasting: 2026 Research on Autophagy and LongevityAugust 08, 2026
Early Markers of Insulin Resistance: Moving Beyond Fasting Blood SugarAugust 08, 2026
Healthcare Management Challenges in India: What Hospital Leaders Must Address NowAugust 08, 2026
Importance of Patient Safety: Why Every Hospital in India Must Prioritize ItAugust 08, 2026
Decoding Fatty Liver Disease: Symptoms, Reversibility, and the MASLD/NAFLD SpectrumAugust 07, 2026
Heart-Healthy Dietary Patterns: Translating Clinical Nutrition Guidelines into Daily MealsAugust 07, 2026